High expression of RNF126 is an independent predictor of a poor prognosis in invasive breast cancer and is considered a potential biomarker for cancer responsiveness to checkpoint kinase 1 (CHK1) inhibitors, as RNF126 increases gene expression of CHK1 in breast cancer cells [40]. Here, CHEK1 is linked to breast cancer.